M42 Health
Zoltan Szepesi is a seasoned financial executive with extensive leadership experience in the healthcare sector. Currently serving as Chief Financial Officer at M42 Health since January 2025, Zoltan previously held the position of Chief Transformation Officer at Diaverum from January 2019 to January 2025, where strategic change initiatives were orchestrated to align organizational goals and engage multidisciplinary stakeholders. Prior to Diaverum, Zoltan was the Chief Transformation Officer at Affidea, a leading investor and operator of healthcare services across Europe, and held various finance roles at Euromedic International, including Interim CFO, Group Controller, and COO Diagnostics. Zoltan’s career began after earning a Master of Science in Economics from the University of Miskolc.
This person is not in any teams
This person is not in any offices
M42 Health
14 followers
M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement. The company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care. M42 has over 20,000 employees and more than 450 facilities in 26 countries around the world. M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, Diaverum, HealthPoint Hospital, the HealthPlus network of specialty centers, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organization & Solutions (IROS), Omics Center of Excellence and National Reference Laboratory, among others.